Can New Biomarker Help Identify High-Risk DLBCL Patients? ...Middle East

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However, clinical trials are needed to clarify the optimal clinical utility. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Can New Biomarker Help Identify High-Risk DLBCL Patients? )

Also on site :

• 'SNL' Icons Reunite With Boss Lorne Michaels For Prestigious Award
• I’m a Celebrity Dermatologist in My 60s and Here’s My 5-Minute Skincare Routine
• America’s first zoning law was about race